Clinical Trial Update: A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]

View source ↗

Summary

This completed Phase 1/2 multicenter randomized trial evaluated the safety and preliminary efficacy of VS101, a subconjunctival latanoprost insert, in adults wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• VS101 subconjunctival latanoprost insert (latanoprost)

Snippet

Sponsor: ViSci Ltd. | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 1, Phase 2 | Status: COMPLETED